CABALETTA BIO INC. -
4,5800
08-ноября-24 10:33:54
15 мин. задержка
Акции
0,0000
0,00%
Сегодняшний диапазон
4,4516 - 4,6100
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
09 ноя 2021 08:00:04 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio Reports Third Quarter 2021 Financial Results and Provides Business Update
01 ноя 2021 07:05:00 Источник Nasdaq GlobeNewswire
-
01 ноя 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the Chardan 5th Annual Genetic Medicines Conference
28 сен 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio Announces Appointment of Michael Gerard as General Counsel
07 сен 2021 08:00:03 Источник Nasdaq GlobeNewswire
-
18 авг 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio Reports Second Quarter 2021 Financial Results and Provides Business Update
05 авг 2021 07:30:01 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio Appoints Biopharmaceutical Leader Scott Brun, M.D. to Board of Directors
28 июн 2021 08:00:00 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the Jefferies Healthcare Conference
27 май 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio Reports First Quarter 2021 Financial Results and Provides New Pipeline Updates
03 май 2021 07:05:00 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio Reports Acute Safety Data from the First Dose Cohort in DesCAARTes™ Trial
03 май 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the 20th Annual Needham Healthcare Conference
07 апр 2021 08:00:02 Источник Nasdaq GlobeNewswire
-
16 мар 2021 07:30:01 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio to Participate in Upcoming Investor Conferences in March
23 фев 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference
07 янв 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
Cabaletta Bio to Participate in Upcoming January Investor Conferences
04 янв 2021 08:00:00 Источник Nasdaq GlobeNewswire